Cork takes brunt of job losses after 40 years of growth
The omens were good when, as early as 1972, a further production plant was already constructed at Ringaskiddy to produce bulk pharmaceutical products.
By 1994, investment had already topped €1bn. Two years later the company began developing Lipitor, the cholesterol drug which would earn the company €10 billion per annum.